InvestSMART

PharmX Technologies Limited (ASX: PHX) - Announcements

Current share price for PHX : $0.082 0.003 (3.53%)+

ASX company news and announcements for PharmX Technologies Limited (PHX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All PharmX Technologies Limited (PHX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than PharmX Technologies Limited (PHX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for PharmX Technologies Limited (PHX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$55 Reinstatement to Quotation 11 Jul 2025 4:59PM $0.088 $0.082 fallen by 6.82%
$55 Supplementary Announcement 11 Jul 2025 4:29PM $0.088 $0.082 fallen by 6.82%
$55 Suspension from Quotation 11 Jul 2025 4:13PM $0.088 $0.082 fallen by 6.82%
$55 Trading Halt 11 Jul 2025 11:01AM $0.088 $0.082 fallen by 6.82%
$55 Pause in trading 11 Jul 2025 9:58AM $0.088 $0.082 fallen by 6.82%
$55 NDSS Agreement Renewal and Supplier Growth Momentum 11 Jul 2025 8:50AM $0.088 $0.082 fallen by 6.82%
$55 Pharmx strengthens Gateway offering with new Pharmacy Portal 26 Jun 2025 11:27AM $0.088 $0.082 fallen by 6.82%
$55 Shareholder Newsletter - May 2025 5 May 2025 3:44PM $0.075 $0.082 risen by 9.33%
$55 Notification regarding unquoted securities - PHX 9 Apr 2025 3:10PM $0.074 $0.082 risen by 10.81%
$55 Pharmx launches new Supplier Portal 3 Apr 2025 9:15AM $0.077 $0.082 risen by 6.49%
$55 Notice of ceasing to be a substantial holder 26 Mar 2025 3:32PM $0.077 $0.082 risen by 6.49%
$55 Pharmx to present at Coffee Microcap Results Webinar 26 Feb 2025 8:37AM $0.082 $0.082 fallen by 0%
$55 H1 FY25 Investor Presentation 19 Feb 2025 8:47AM $0.083 $0.082 fallen by 1.20%
$55 H1 FY25 Results Announcement 19 Feb 2025 8:46AM $0.083 $0.082 fallen by 1.20%
$55 Half Yearly Report and Accounts 19 Feb 2025 8:45AM $0.083 $0.082 fallen by 1.20%
$55 Pharmx announces strategic partnership with Toniq 18 Feb 2025 10:47AM $0.083 $0.082 fallen by 1.20%
$55 Notice of Results Announcement 3 Feb 2025 1:25PM $0.077 $0.082 risen by 6.49%
$55 Change of Company Secretary 28 Nov 2024 9:08AM $0.069 $0.082 risen by 18.84%
$55 Results of Annual General Meeting 26 Nov 2024 1:42PM $0.075 $0.082 risen by 9.33%
$55 Chairman's Address & AGM Presentation 26 Nov 2024 9:28AM $0.071 $0.082 risen by 15.49%
$55 Notification of cessation of securities - PHX 21 Nov 2024 8:22AM $0.057 $0.082 risen by 43.86%
$55 Investor Presentation 30 Oct 2024 1:53PM $0.043 $0.082 risen by 90.70%
$55 Notice of Annual General Meeting/Proxy Form 25 Oct 2024 9:06AM $0.042 $0.082 risen by 95.24%
$55 Initial Director's Interest Notice 9 Sep 2024 9:55AM $0.050 $0.082 risen by 64%
$55 Alternate Director 9 Sep 2024 9:07AM $0.050 $0.082 risen by 64%

51 - 75 of 106 results

Page 3 of 5

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.